Pradaxa Bleeding Risk Gets Deeper FDA Scrutiny In Mini-Sentinel Project
This article was originally published in The Pink Sheet Daily
Executive Summary
A 2012 Sentinel study didn’t find any problems, but FDA wants a closer look now that the dataset has grown.